バイオプロセス技術の世界市場

バイオプロセス技術の世界市場は2030年までに685億米ドルに達する見込み

2024年に347億米ドルと推定されるバイオプロセス技術の世界市場は、2024～2030年の分析期間においてCAGR 12.0%で成長し、2030年には685億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである生物製剤安全性試験は、CAGR 11.7%を記録し、分析期間終了までに178億米ドルに達すると予測されます。細胞培養分野の成長率は、分析期間中CAGR13.6％と推定されます。

米国市場は94億米ドルと推定、中国はCAGR16.1％で成長予測

米国のバイオプロセス技術市場は2024年に94億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに143億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは16.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.8%と10.6%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界のバイオプロセス技術市場- 主要動向と促進要因のまとめ

バイオプロセス技術が生物製剤、先端治療薬、次世代バイオ医薬品の製造に欠かせない理由とは？

バイオプロセス技術は、モノクローナル抗体、組換えタンパク質、ワクチン、細胞・遺伝子治療などの複雑な生物製剤を、厳密に管理された再現性の高いスケーラブルな条件で製造することを可能にし、バイオ医薬品製造の中核を形成しています。上流工程（細胞株開発、発酵、バイオリアクター培養）と下流工程（ろ過、クロマトグラフィー、精製）を含み、生きた細胞系を高純度の治療活性製品に変換します。生物学的製剤が新薬パイプラインの大半を占め続ける中、バイオプロセス技術は治療効果、コンプライアンス、商業的スケーラビリティを戦略的に実現するものとなっています。

低分子医薬品の製造とは異なり、生物製剤の製造は本質的に変化しやすく、高度なバイオプロセス管理、高品位原料、厳格な環境モニタリングが必要となります。細胞の生存率を維持し、一貫した発現収率を確保し、バッチ間で製品の品質を維持する能力が最も重要です。バイオプロセス・プラットフォームは、連続製造のための灌流システム、遺伝子治療のためのウイルスベクター・プラットフォーム、CAR-T細胞製造のためのクローズドシステム・バイオリアクターなど、特定の治療タイプに合わせて調整されるようになってきており、それぞれに異なる性能とコンプライアンスが求められています。

個別化治療の多品種少量生産へと業界がシフトする中、バイオプロセス技術は、より小さなバッチサイズ、より迅速な切り替え、モジュール化された設備設計を可能にするよう適応しています。バイオプロセスエンジニアリング、デジタル制御、リアルタイム分析の融合により、プロセスの集約化と精密製造が可能になり、バイオプロセス技術は将来対応可能な生物製剤インフラの要として位置づけられています。

プロセス集約化、デジタル統合、シングルユースシステムは、バイオプロセス技術プラットフォームをどのように形成しているのでしょうか？

プロセスの集約化が重要な推進力として台頭しており、メーカーは、フットプリントの削減、収率の向上、グラム当たりのコストの低減のために、高細胞密度培養システム、灌流バイオリアクター、連続的な下流精製を採用しています。これらの戦略は、パンデミック対応ワクチンや希少疾患治療薬を含む重要な生物製剤の生産スケジュールを、品質や規制遵守を損なうことなく加速するために用いられています。連続製造はまた、リアルタイムの工程調整と開発サイクルの短縮を可能にし、時間に敏感な臨床パイプラインにとって大きな利点となっています。

PAT（プロセス分析技術）、モデルベース制御システム、AI駆動型分析などのデジタルツールの統合は、バイオプロセスの設計、モニタリング、最適化の方法を変革しています。デジタルツイン、クラウドベースのバッチ記録、および予知保全プラットフォームは、プロセスの逸脱の早期発見を可能にし、プロアクティブな意思決定を促進するクローズドループフィードバックシステムをサポートしています。これらのツールはまた、規制文書化を強化し、バッチの失敗を減らし、サイトやCDMOパートナーシップ間での技術移転の成果を向上させています。

シングルユース・バイオプロセシングシステムは、その柔軟性、洗浄バリデーションの負担軽減、コンタミネーションコントロールの改善により、特に上流工程で支持され続けています。滅菌済みの使い捨てバイオリアクター、チューブセット、ろ過カートリッジは、迅速なスケールアップとスケールダウンを可能にし、多品種生産施設や臨床製造に理想的です。コスト、持続可能性、廃棄物管理への懸念が残る中、サプライヤーはリサイクル可能でハイブリッドなシングルユースソリューションを推進し、商業的および開発的な環境における価値提案を維持しています。

バイオプロセス技術の進化を加速させている治療領域、地域エコシステム、製造モデルは？

モノクローナル抗体、バイオシミラー、ワクチン、そしてRNAベース治療やウイルスベクターベースの遺伝子治療などの新しい治療法が、バイオプロセス技術への投資を促進する主な応用分野です。これらの製品は複雑であるため、臨床と商業の両方のサプライチェーンにおいて、安定性、効力、バッチ間の一貫性を確保するためのバイオプロセス構成が要求されます。免疫学的、腫瘍学的、感染症を適応症とするこれらの治療薬の多くでは、迅速で適応性が高く、コンプライアンスに適合した製造ソリューションへの需要がますます高まっています。

北米と西欧は依然として技術革新と投資の中心地であり、大規模なバイオ医薬品メーカー、アカデミック・センター・オブ・エクセレンス、ハイスペックなインフラを提供するCDMOが牽引しています。アジア太平洋、特に中国、インド、韓国は、政府が支援するバイオテクノロジー・イニシアチブと生物製剤製造の現地化戦略により、急速に生産能力を拡大しています。これらの地域は、モジュール式GMP施設、地域技術移転センター、統合供給ネットワークに投資し、バイオプロセス技術アクセスと主権を強化しています。

特に複数の生物製剤パイプラインを管理する企業にとっては、自社インフラと外注CDMOの能力を組み合わせたハイブリッド製造モデルが標準になりつつあります。柔軟なキャパシティ展開、エンド・ツー・エンドのプロセス開発サービス、製造イノベーションへの共同投資により、従来の「作るか、買うか」の計算が再構築されつつあります。医薬品開発企業が生産リスクの軽減と市場参入の迅速化を目指す中、スケーラブルなプラットフォーム、規制に関する専門知識、世界展開能力を持つ新興国市場プロバイダーが、好ましい戦略的パートナーとして台頭してきています。

バイオプロセス技術市場の成長を促進する要因とは？

バイオプロセス技術市場は、生物製剤、細胞ベース療法、精密バイオマニュファクチャリングへの需要が世界的に加速するにつれて拡大しています。プロセスの拡張性、柔軟性、品質保証は、新規治療薬をより早く、より安全に、よりコスト効率よく市場に投入する上で、今や重要な差別化要因となっています。

主な成長促進要因としては、連続的かつ強化されたバイオプロセスの台頭、シングルユースシステムの広範な採用、デジタルモニタリングとAI主導のプロセス制御の統合、世界のバイオ製造能力の向上などが挙げられます。プラットフォーム技術とモジュール式インフラストラクチャーの革新は、多様化する治療パイプラインの商業的即応性をさらに高めています。

バイオ製薬企業は、複雑な治療法を、短縮されたタイムラインと厳しくなった規制当局の監視の下で提供しようと奮闘しているが、バイオプロセス技術は、バイオ製薬製造の新時代の基盤となるアーキテクチャになり得るだろうか。

セグメント

製品タイプ（生物製剤安全性試験、細胞培養、細胞増設、細胞株開発、フローサイトメトリー、タンジェンシャルフローろ過、フローサイトメトリー）、用途（抗生物質、バイオシミラー、組換えタンパク質、その他の用途）、最終用途（バイオ製薬会社、受託製造機関、学術研究機関、その他の最終用途）

調査対象企業の例（注目32社）

• Advanced Instruments, LLC
• Becton, Dickinson and Company（BD）
• Bio-Rad Laboratories, Inc.
• Corning Incorporated
• Danaher Corporation
• Eppendorf AG
• GE Healthcare
• Genedata AG
• Lonza Group AG
• Merck KGaA
• MilliporeSigma（Merck Group）
• Nova Biomedical
• Pall Corporation
• Repligen Corporation
• Sartorius AG
• Siemens Healthineers AG
• Stamm Biotech
• Thermo Fisher Scientific Inc.
• Univercells SA
• ZETA GmbH

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bio-Process Technology Market to Reach US$68.5 Billion by 2030

The global market for Bio-Process Technology estimated at US$34.7 Billion in the year 2024, is expected to reach US$68.5 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Biologics Safety Testing, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$17.8 Billion by the end of the analysis period. Growth in the Cell Culture segment is estimated at 13.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.4 Billion While China is Forecast to Grow at 16.1% CAGR

The Bio-Process Technology market in the U.S. is estimated at US$9.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$14.3 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 10.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Bio-Process Technology Market - Key Trends & Drivers Summarized

Why Is Bio-Process Technology Central to the Manufacturing of Biologics, Advanced Therapies, and Next-Generation Biopharmaceuticals?

Bio-process technology forms the operational core of biopharmaceutical manufacturing, enabling the production of complex biologics-including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies-under tightly controlled, reproducible, and scalable conditions. It encompasses upstream (cell line development, fermentation, bioreactor culture) and downstream (filtration, chromatography, purification) processes that convert living cell systems into high-purity, therapeutically active products. As biologics continue to dominate new drug pipelines, bio-process technology has become a strategic enabler of therapeutic efficacy, compliance, and commercial scalability.

Unlike small-molecule production, biologics manufacturing is inherently variable, requiring sophisticated bioprocess controls, high-grade raw materials, and stringent environmental monitoring. The ability to maintain cell viability, ensure consistent expression yields, and preserve product quality across batches is paramount. Bio-process platforms are increasingly being tailored to specific therapy types, such as perfusion systems for continuous manufacturing, viral vector platforms for gene therapy, or closed-system bioreactors for CAR-T cell production-each with distinct performance and compliance demands.

As the industry shifts toward high-mix, low-volume production of personalized therapies, bio-process technology is adapting to enable smaller batch sizes, faster changeovers, and modular facility design. The convergence of bioprocess engineering, digital controls, and real-time analytics is allowing for greater process intensification and precision manufacturing, positioning bio-process technology as a linchpin of future-ready biologics infrastructure.

How Are Process Intensification, Digital Integration, and Single-Use Systems Reshaping Bio-Process Technology Platforms?

Process intensification is emerging as a key driver, with manufacturers adopting high-cell-density culture systems, perfusion bioreactors, and continuous downstream purification to reduce footprint, increase yield, and lower cost per gram. These strategies are being used to accelerate production timelines for critical biologics-including pandemic-response vaccines and rare disease therapies-without compromising quality or regulatory adherence. Continuous manufacturing is also enabling real-time process adjustments and shorter development cycles, a major advantage for time-sensitive clinical pipelines.

The integration of digital tools-such as PAT (Process Analytical Technology), model-based control systems, and AI-driven analytics-is transforming how bioprocesses are designed, monitored, and optimized. Digital twins, cloud-based batch records, and predictive maintenance platforms are supporting closed-loop feedback systems that enable early detection of process deviations and facilitate proactive decision-making. These tools are also strengthening regulatory documentation, reducing batch failures, and improving tech transfer outcomes across sites and CDMO partnerships.

Single-use bioprocessing systems continue to gain traction, particularly in upstream operations, due to their flexibility, reduced cleaning validation burden, and improved contamination control. Pre-sterilized disposable bioreactors, tubing sets, and filtration cartridges support rapid scale-up and scale-down operations, making them ideal for multi-product facilities and clinical manufacturing. As cost, sustainability, and waste management remain concerns, suppliers are advancing recyclable and hybrid single-use solutions to maintain the value proposition across both commercial and developmental settings.

Which Therapeutic Areas, Regional Ecosystems, and Manufacturing Models Are Accelerating the Evolution of Bio-Process Technology?

Monoclonal antibodies, biosimilars, vaccines, and emerging modalities such as RNA-based therapies and viral vector-based gene treatments are the primary application areas driving investment in bio-process technology. The complexity of these products demands tailored bioprocess configurations that ensure stability, potency, and batch-to-batch consistency across both clinical and commercial supply chains. With many of these therapies targeting immunological, oncological, and infectious disease indications, the demand for rapid, adaptive, and compliant manufacturing solutions continues to intensify.

North America and Western Europe remain the epicenters of innovation and investment, led by large-scale biomanufacturers, academic centers of excellence, and CDMOs offering high-spec infrastructure. Asia-Pacific-particularly China, India, and South Korea-is rapidly scaling capacity through government-backed biotech initiatives and localization strategies for biologics manufacturing. These regions are investing in modular GMP facilities, regional tech transfer centers, and integrated supply networks to strengthen bio-process technology access and sovereignty.

Hybrid manufacturing models combining in-house infrastructure with outsourced CDMO capacity are becoming standard, especially for companies managing multiple biologics pipelines. Flexible capacity deployment, end-to-end process development services, and co-investment in manufacturing innovation are reshaping the traditional make-or-buy calculus. As drug developers seek to derisk production and accelerate market entry, bio-process technology providers with scalable platforms, regulatory expertise, and global deployment capabilities are emerging as preferred strategic partners.

What Are the Factors Driving Growth in the Bio-Process Technology Market?

The bio-process technology market is expanding as demand for biologics, cell-based therapies, and precision biomanufacturing accelerates globally. Process scalability, flexibility, and quality assurance are now critical differentiators in bringing novel therapeutics to market faster, safer, and more cost-effectively.

Key growth drivers include the rise of continuous and intensified bioprocessing, widespread adoption of single-use systems, integration of digital monitoring and AI-driven process controls, and increasing global biomanufacturing capacity. Innovation in platform technologies and modular infrastructure is further amplifying commercial readiness across diversified therapeutic pipelines.

As biopharma companies race to deliver complex therapies under compressed timelines and heightened regulatory scrutiny, could bio-process technology become the foundational architecture for a new era of biologics manufacturing-where agility, precision, and resilience define global competitiveness?

SCOPE OF STUDY:

The report analyzes the Bio-Process Technology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, Flow Cytometry); Application (Antibiotics, Biosimilars, Recombinant Proteins, Other Applications); End-Use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Advanced Instruments, LLC
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Corning Incorporated
• Danaher Corporation
• Eppendorf AG
• GE Healthcare
• Genedata AG
• Lonza Group AG
• Merck KGaA
• MilliporeSigma (Merck Group)
• Nova Biomedical
• Pall Corporation
• Repligen Corporation
• Sartorius AG
• Siemens Healthineers AG
• Stamm Biotech
• Thermo Fisher Scientific Inc.
• Univercells SA
• ZETA GmbH

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Bio-Process Technology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Adoption of Advanced Biomanufacturing Techniques Throws the Spotlight on Bio-Process Technology Innovation
  • Growth in Recombinant Protein, mAb, and Cell Therapy Pipelines Spurs Need for Scalable and Reproducible Processes
  • OEM Focus on Single-Use Bioreactors, Sensors, and Chromatography Systems Enhances Process Efficiency
  • Use of Automation, PAT, and Digital Twin Technologies Improves Process Monitoring and Quality Control
  • OEM Development of Modular and Flexible Facility Designs Supports Rapid Scale-Up and Multi-Product Production
  • Demand for High-Titer, High-Yield Expression Systems Encourages Innovation in Host Cell and Media Engineering
  • Collaborations Between Biotech Firms and Equipment Providers Accelerate Tech Transfer and Commercial Readiness
  • Increased Investment in Regional Manufacturing Capabilities Supports Technology Localization
  • Rising Complexity in Biologics Formulations Drives Need for Custom-Tailored Bio-Processing Platforms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bio-Process Technology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bio-Process Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bio-Process Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Bio-Process Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Biologics Safety Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Biologics Safety Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Biologics Safety Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Tangential Flow Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Tangential Flow Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Tangential Flow Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Recombinant Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Biosimilars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Biosimilars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Biosimilars by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Academic Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Academic Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Academic Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Bio-Process Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Bio-Process Technology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Bio-Process Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 125: UK Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 131: UK Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 140: Spain Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 149: Russia Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Bio-Process Technology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Bio-Process Technology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 179: Australia Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 182: India Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 188: India Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Bio-Process Technology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Bio-Process Technology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Bio-Process Technology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Bio-Process Technology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 275: Iran Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 284: Israel Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 302: UAE Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Bio-Process Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Bio-Process Technology by Product Type - Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Bio-Process Technology by Product Type - Percentage Breakdown of Value Sales for Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Bio-Process Technology by Application - Recombinant Proteins, Other Applications, Antibiotics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Bio-Process Technology by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Other Applications, Antibiotics and Biosimilars for the Years 2015, 2025 & 2030
  • TABLE 320: Africa Recent Past, Current & Future Analysis for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for Bio-Process Technology by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for Bio-Process Technology by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION